Open original FDA record ↗Recall record
- FDA identifier
- Z-1314-2026
- Company in FDA record
- Hologic, Inc
- FDA classification date
- Feb 6, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Presence of particulates in affected devices that can be deposited into breast tissue during use.
Source facts
- Action
- An URGENT FIELD SAFETY NOTICE (REMOVAL) was mailed to consignees on 1/2/26. The notification instructs consignees to quarantine affected devices and return them through IQVIA per the instructions provided on the Recall Response Form. The recall notification should be forwarded within consignee locations to users and to any facility to which product was further distributed. A copy of the recall notification is to be posted for awareness at consignee locations. Questions can be directed to BreastHealth.Support@hologic.com or by phone at 1-877-371-4372. An updated FIELD TECHNICAL BULLETIN dated May 2026 was distributed to consignees. This technical bulletin provides guidance to healthcare providers on how to utilize the Brevera Breast Biopsy System without the use of the Brevera 9 Gauge Biopsy Needle. Questions can be directed to BreastHealth.Support@hologic.com or by phone at 1-877-371-4372.
- Initiated
- 2025-12-15
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution.
- Recall number
- Z-1314-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217778
- FDA classified
- 2026-02-06
- Recall event number
- 98172